Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • CYTORI THERAPEUTICS INC Financial Overview

  • Income Statement: CYTX

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 6.85 M 6.05 M 804,000.00 11.73%
    Gross Profit 3.47 M 4.01 M -545,000.00 -15.72%
    Net Income Before Extra Items/Preferred Div -30.04 M -28.67 M -1.36 M 4.54%
    Operating Income -28.70 M -31.25 M 2.55 M -8.88%
  • Cash Flow: CYTX

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 34.93 M 26.58 M 8.35 M 23.91%
    Net Cash Flow - Investing 393,000.00 -5.98 M 6.38 M 1,622.14%
    Net Cash Flow/Operating Activities -33.39 M -30.00 M -3.39 M 10.17%
  • Balance Sheet: CYTX

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 25.61 M 21.51 M 4.10 M 16.02%
    Total Liabilities 33.33 M 30.91 M 2.42 M 7.26%
    Shareholders Equity -7.72 M -9.40 M 1.68 M -21.81%
  • Key Ratios / Statistics: CYTX

    • Valuation

      Price/Earnings (TTM) -3.22
      Price/Sales (TTM) 14.16
      Price/Book (MRQ) -148.62
      Price/Cash Flow (TTM) -8.01
    • Profitability

      Gross Margin 50.58
      Operating Margin -418.81
      Profit Margin -438.29
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 2.03
      Current Ratio (MRQ) 2.83
      Long Term Debt-to-Equity (MRQ) -451.59
    • Management Effectiveness

      Return on Equity (TTM) -700.99
      Return on Assets (TTM) -91.64
      Return on Investments (TTM) -473.15